AI English summary of an SEC filing — figures as filed
Biogen said it appointed Sean Godbout as Vice President, Chief Accounting Officer & Global Corporate Controller and designated him as principal accounting officer, with both actions effective as of January 13, 2025 March 1, 2025.
Key points
AI summaryBiogen said it appointed Sean Godbout as Vice President, Chief Accounting Officer & Global Corporate Controller and designated him as principal accounting officer, with both actions effective as of January 13, 2025 March 1, 2025.
The company said Robin Kramer, its current Chief Accounting Officer, will no longer be designated as principal accounting officer as of the effective date of Godbout's appointment. Michael McDonnell will retire on March 1, 2025, and as previously announced, Kramer will become Chief Financial Officer upon his retirement.
Biogen said Godbout is 50 years old and joined the company in 2007. He has served as Global Corporate Controller since October 2023 and was Corporate Controller from September 2019 to October 2023. Before joining Biogen, he worked at PricewaterhouseCoopers LLP. He is a Certified Public Accountant in Massachusetts.
The company said Godbout's base salary will be $400,000 and his target bonus under the annual bonus plan will be 40% of his annual base salary. Upon termination without cause, he would receive a lump sum of at least 6 months of base salary and target bonus, plus 1 month for each full year of service, up to a maximum of 12 months, with 1 year(s) of service as the reference point for the increment. If he is terminated without cause or involuntarily within 2 years after a corporate transaction or change in control, he would receive a lump sum equal to 1 times his annual base salary plus target bonus.
Summary
AI-writtenAnalysis scope · Filing bodyWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.
Sean Godbout Appointed Chief Accounting Officer
Biogen said it appointed Sean Godbout as Vice President, Chief Accounting Officer & Global Corporate Controller and designated him as principal accounting officer, with both actions effective as of January 13, 2025 March 1, 2025.
Source · Based on the filing body and exhibits
Robin Kramer Designation Change and Michael McDonnell Retirement
The company said Robin Kramer, its current Chief Accounting Officer, will no longer be designated as principal accounting officer as of the effective date of Godbout's appointment. Michael McDonnell will retire on March 1, 2025, and as previously announced, Kramer will become Chief Financial Officer upon his retirement.
Source · Based on the filing body and exhibits
Godbout Background
Biogen said Godbout is 50 years old and joined the company in 2007. He has served as Global Corporate Controller since October 2023 and was Corporate Controller from September 2019 to October 2023. Before joining Biogen, he worked at PricewaterhouseCoopers LLP. He is a Certified Public Accountant in Massachusetts.
Source · Based on the filing body and exhibits
Godbout Compensation and Severance Terms
The company said Godbout's base salary will be $400,000 and his target bonus under the annual bonus plan will be 40% of his annual base salary. Upon termination without cause, he would receive a lump sum of at least 6 months of base salary and target bonus, plus 1 month for each full year of service, up to a maximum of 12 months, with 1 year(s) of service as the reference point for the increment. If he is terminated without cause or involuntarily within 2 years after a corporate transaction or change in control, he would receive a lump sum equal to 1 times his annual base salary plus target bonus.
Source · Based on the filing body and exhibits
AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.
Original filing
The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.
Loading the filing text…